4DMedical rallies after inking a deal with UC San Diego Health
Make us a preferred source
Make us a preferred source on Google
The news: Respiratory imaging technology company 4DMedical surged in early trade after announcing a commercial agreement with US-based academic health system UC San Diego Health (UCSD) for the clinical use of its medical imaging software, CT:VQ.
The deal marks the fourth US academic centre to adopt CT:VQ, following Stanford, the University of Miami and the Cleveland Clinic.
Shares rallied 14.56% to $4.80 per share as of 11:12am AEDT.
The context: The commercial launch of CT:VQ forms part of 4DMedical’s ongoing commercialisation strategy following FDA clearance received last year.
UCSD, led by Dr Jonathan Chung, chief of the division of cardiothoracic imaging and professor of radiology, has commenced clinical use of CT:VQ under a structured launch framework, with introductory pricing to begin from 31 March before transitioning to full commercial terms.
What they said: “In just over four months since FDA clearance, we’ve established CT:VQ at four of America’s leading academic centres,” 4DMedical CEO and founder Andreas Fouras said.
“This rapid adoption by elite institutions demonstrates both the transformative potential of CT:VQ and the strength of out go-to-market execution.”
The source: ASX
